Axsome Therapeutics said it's dopamine and norepinephrine reuptake inhibitor solriamfetol (Sunosi), approved for excessive ...

Phthalates — the synthetic chemicals used in everyday products for food packaging, personal care, toys and more — have been linked to abnormal neurological development in infants.

Animal studies could lead to blood tests that could guide doctors in better matching drugs to patients based on immune system biomarkers.

Shares of GRI Bio Inc. (NASDAQ:GRI) were trading at $6.28, up $3.08, or 96%, after the firm reported interim safety results from the ongoing phase IIa study testing GRI-0621 for idiopathic pulmonary ...

Medically reviewed by Lindsay Cook, PharmD Weight loss medications can be an effective option for people struggling to lose ...

Scientists have uncovered a dedicated brain circuit that distinguishes between direct fear and fear learned by observing ...

Axsome Therapeutics (AXSM) stock falls as its depression drug solriamfetol fails in a Phase 3 trial for those with daytime ...

Transcend also saw significant improvements on secondary endpoints that assessed the rate of response, remission and loss of ...

To stop fighting with your partner, you have to be able to get past the power struggle stage and into the "stability" stage.

Topline data were announced from a phase 3 trial evaluating solriamfetol in adults with attention deficit hyperactivity disorder (ADHD).

The following is a summary of “Ability of diastolic arterial pressure to better characterize the severity of septic shock ...